FENC Fennec Pharmaceuticals Inc
Company Analysis
Latest News
🔴 Fennec Pharmaceuticals is trading 5.7% down today as biotech shares fall 2.47%
Fennec Pharmaceuticals is trading 5.7% down at $11.20 amid a broad biotech-sector pullback. - Biotech shares fell 2.47% during regular trading. - No new...
🔴 Fennec Pharmaceuticals is trading 5.3% down today
Fennec Pharmaceuticals is trading at $12.10, down 5.32%, with no new company-specific announcement, downgrade, financing, or regulatory event clearly...
🟢 Fennec Pharmaceuticals is trading 10.69% up today after second-quarter sales rose 78% year over year
Fennec Pharmaceuticals is trading 10.69% up at $12.11 after reporting strong second-quarter 2026 results before the August 11, 2026 market open. - Net product...
🟢 Fennec Pharmaceuticals is trading 9% up today after strong second-quarter 2026 results
Fennec Pharmaceuticals is trading 9% up at $11.93 after reporting strong second-quarter 2026 results before the August 11, 2026 market open. - Net product...
🟢 Fennec Pharmaceuticals is trading 6.6% up in pre-market ahead of Q2 2026 results
Fennec Pharmaceuticals is trading 6.58% up now at $11.66 as investors positioned ahead of its second-quarter 2026 financial results, due before the U.S. market...
Fennec Pharma Surges 7.9% Into Earnings Morning — Can a One-Drug Company Sustain Its Breakneck Growth?
Shares jumped to $11.80 in after-hours trading on August 10, reversing a 5.49% regular-session decline, as investors scrambled to position ahead of Fennec...
🟢 Fennec Pharmaceuticals is trading 7.86% up in after-hours trading ahead of second-quarter 2026 results
Fennec Pharmaceuticals is trading at $11.80, up +7.86% in after-hours trading, ahead of second-quarter 2026 results. - The move followed a 5.49%...
🔴 Fennec Pharmaceuticals is trading 5.46% down today ahead of second-quarter results
Fennec Pharmaceuticals is trading 5.46% down at $10.94, with no clear company-specific negative announcement identified for August 10, 2026. - Second-quarter...
Fennec Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Fennec Pharmaceuticals is projected to report Q2 2026 revenue of approximately $16.21 million and an EPS of $0.02, while the stock trades at $11.57 against a...
🟢 Fennec Pharmaceuticals is trading 6% up today amid biotech-sector strength
Fennec Pharmaceuticals is trading at $11.49, up +6.00%, with the move appearing aligned with biotech-sector strength. - No company-specific announcement dated...
🟢 Fennec Pharmaceuticals is trading 6% up today amid a biotech rally and broader risk-on sentiment
Fennec Pharmaceuticals is trading 6% up today at $10.72 as a rally in biotech stocks and broader risk-on sentiment drive the stock higher. • The move extends...
🟢 Fennec Pharmaceuticals is trading 5.11% up today amid a broader risk-on market rally
Fennec Pharmaceuticals is trading at $10.08 (+5.11%) today as the stock benefits from a broader risk-on tape and positive sentiment across the biotech...
🔴 Fennec Pharmaceuticals is trading 9.3% down today with no clear company-specific catalyst identified
Fennec Pharmaceuticals is trading at $8.75, down 9.3% in after-hours trading, with no clear company-specific catalyst identified for the move. The stock...
🟢 Fennec Pharmaceuticals is trading 5.9% up today
Fennec Pharmaceuticals is trading at $10.75 (+5.91%) today, though no clear company-specific catalyst has been identified to explain the move. • The price...
🟢 Fennec Pharmaceuticals is trading 5.1% up today amid a broader biotech rebound
Fennec Pharmaceuticals is trading 5.1% up at $10.40, rebounding from yesterday’s decline as the stock benefits from a broader risk-on tone and strength across...
🔴 Fennec Pharmaceuticals is trading 5% down today with no clear company-specific catalyst
Fennec Pharmaceuticals is trading at $9.97 (-5.05%) with no clear company-specific catalyst identified for the downward move. • Recent corporate developments,...
🔴 Fennec Pharmaceuticals is trading 8.2% down today as it pulls back after a multi-day run and earnings-driven volatility
Fennec Pharmaceuticals is trading at $10.25 (-8.2%) in pre-market, pulling back after a strong multi-day run as investors continue to digest recent financial...